Orthocell Ltd has released a press release.
Orthocell Receives A$2.1m R&D Tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- Notification regarding unquoted securities - OCC
- Regulatory Approval for Remplir Nerve Repair Device
- Striate US Market Entry Update
- Application for quotation of securities - OCC
- Successful SmrtGraft Shoulder Study Published
Later from Orthocell
- Final Data Readout for Orthocells Nerve Reconstruction Study
- OCC Signs Striate Global License And Manufacturing Agreement
- Striate Global License and Distribution Agreement Update
- Final Report and Annual Report to Shareholders
- Appointment of Exclusive Australian Distributor for Remplir
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell